Ind-Swift Laboratories Limited
INDSWFTLAB.BO·BSE·Healthcare
346.90−5.50 (−1.56%)today
As of Oct 21, 11:49 AM IST · May be delayed up to 15 min · INR
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close352.40
Open352.40
Day range342.55365.00
52-week range87.00424.55
Off day high−4.96%
Off 52-week high−18.29%
Volume38.91K
Avg. volume (3M)62.90K
Market cap30.65B
EPS (TTM)6.69
Forward P/E—
P/E ratio (TTM)51.85
Dividend yield—
Beta (5Y)0.79
Shares outstanding88.36M
Short interest—
Earnings dateAug 11, 2025 (est.)
Analyst target—
Profit margin8.50%
Against its peers
Compare in full ›| INDSWFTLAB.BO | AARTIDRUGS.BO | SOLARA.NS | IOLCP.NS | MOREPENLAB.NS | 000513.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 30.65B | 35.59B | 31.28B | 51.14B | 63.24B | 23.94B |
| P/E (TTM) | 51.9 | 18.6 | 84.1 | 30.5 | 45.1 | 14.3 |
| Forward P/E | — | 14.0 | 20.6 | 16.8 | — | 10.7 |
| Price/book | 2.1 | 2.3 | 2.2 | 2.8 | 5.2 | 1.8 |
| Dividend yield | — | 0.50% | — | 0.55% | 0.16% | 8.99% |
| 1-year change | +243.47% | −21.36% | +8.51% | +92.46% | +147.18% | −27.28% |
| Today | −1.56% | −2.29% | +0.40% | −4.85% | −5.00% | −1.03% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All INDSWFTLAB.BO news ›Essix Biosciences Acquires 14 lakh Equity Shares Of Ind-Swift Laboratories
Free Press Journal Mumbai: Essix Biosciences Limited, an acquirer belonging to the promoter group of Ind-Swift Laboratories Limited, has acquired 14 lakh equity shares of the target company The acquisition took place on October 8, 2026,…
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Mixedsentiment
Mentioned with
People in the coverage
Most coverage from
-
freepressjournal.in1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.